Germany · Delayed Price · Currency is EUR Rhythm Biosciences Statistics
Total Valuation
FRA:0RY has a market cap or net worth of EUR 9.09 million. The enterprise value is 6.68 million.
| Market Cap | 9.09M |
| Enterprise Value | 6.68M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 284.08M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.11% |
| Shares Change (QoQ) | +8.81% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 210.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.80 |
| PB Ratio | 3.12 |
| P/TBV Ratio | 3.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.13 |
| EV / Sales | 3.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.27 |
Financial Position
The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.87 |
| Quick Ratio | 4.58 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -35.62 |
Financial Efficiency
Return on equity (ROE) is -71.10% and return on invested capital (ROIC) is -41.98%.
| Return on Equity (ROE) | -71.10% |
| Return on Assets (ROA) | -33.68% |
| Return on Invested Capital (ROIC) | -41.98% |
| Return on Capital Employed (ROCE) | -42.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.80 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.79% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.79% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 50 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:0RY had revenue of EUR 1.89 million and -1.30 million in losses. Loss per share was -0.01.
| Revenue | 1.89M |
| Gross Profit | 2.40M |
| Operating Income | -1.27M |
| Pretax Income | -1.30M |
| Net Income | -1.30M |
| EBITDA | -1.21M |
| EBIT | -1.27M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2.66 million in cash and 94,838 in debt, giving a net cash position of 2.57 million.
| Cash & Cash Equivalents | 2.66M |
| Total Debt | 94,838 |
| Net Cash | 2.57M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.92M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.29M |
Cash Flow
In the last 12 months, operating cash flow was -1.27 million and capital expenditures -953, giving a free cash flow of -1.27 million.
| Operating Cash Flow | -1.27M |
| Capital Expenditures | -953 |
| Free Cash Flow | -1.27M |
| FCF Per Share | n/a |
Margins
Gross margin is 126.84%, with operating and profit margins of -67.03% and -68.73%.
| Gross Margin | 126.84% |
| Operating Margin | -67.03% |
| Pretax Margin | -68.73% |
| Profit Margin | -68.73% |
| EBITDA Margin | -63.88% |
| EBIT Margin | -67.03% |
| FCF Margin | n/a |
Dividends & Yields
FRA:0RY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.11% |
| Shareholder Yield | n/a |
| Earnings Yield | -14.32% |
| FCF Yield | -13.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:0RY has an Altman Z-Score of 3.2 and a Piotroski F-Score of 4.
| Altman Z-Score | 3.2 |
| Piotroski F-Score | 4 |